Schiestl R H
Department of Molecular and Cellular Toxicology, Harvard University School of Public Health, Boston, MA 02115.
Environ Health Perspect. 1993 Dec;101 Suppl 5(Suppl 5):179-84. doi: 10.1289/ehp.93101s5179.
A large number of animal and human carcinogens without apparent genotoxic activity exist (nonmutagenic carcinogens) that are difficult or impossible to detect with the currently used short-term tests. Because of the association of carcinogenesis with genome rearrangement, a system selecting for intrachromosomal recombination (DEL recombination) that results in genome rearrangement has been constructed in the yeast Saccharomyces cerevisiae. Because DEL recombination is under different genetic control than interchromosomal recombination and meiotic recombination, it is probably due to a different mechanism. It has been found that DEL recombination is readily inducible by 10 mutagenic carcinogens and 17 nonmutagenic carcinogens that are not detectable (false negatives) with the Ames assay. In addition, three out of four mutagens that do not cause cancer (false positives in the Ames assay) do not induce DEL recombination. DEL recombination is inducible by UV only in dividing cells but not in cells synchronized in the G1 or G2 phase of the cell cycle. Interchromosomal recombination, on the other hand, is inducible in G1 but not in G2. The nonmutagenic carcinogens induce DEL recombination only in actively growing cells, which may give some indication as to their mechanism. Further characterization of the mechanism involved in induction of DEL recombination may contribute to the understanding of the biological activity of nonmutagenic carcinogens.
存在大量无明显基因毒性活性的动物和人类致癌物(非诱变致癌物),用目前使用的短期试验很难或无法检测到。由于致癌作用与基因组重排相关,已在酿酒酵母中构建了一种用于选择导致基因组重排的染色体内重组(DEL重组)的系统。由于DEL重组受与染色体间重组和减数分裂重组不同的遗传控制,其机制可能不同。已发现,DEL重组很容易被10种诱变致癌物和17种用艾姆斯试验无法检测到(假阴性)的非诱变致癌物诱导。此外,四种不致癌的诱变剂(艾姆斯试验中的假阳性)中有三种不会诱导DEL重组。DEL重组仅在分裂细胞中可被紫外线诱导,而在细胞周期G1或G2期同步化的细胞中则不会。另一方面,染色体间重组在G1期可诱导,但在G2期则不会。非诱变致癌物仅在活跃生长的细胞中诱导DEL重组,这可能为其作用机制提供一些线索。对DEL重组诱导机制的进一步表征可能有助于理解非诱变致癌物的生物学活性。